20-Nov-2024
Cardinal Health launches Kendall SCD SmartFlow Compression System
PRNewswire (Wed, 20-Nov 7:30 AM ET)
High Alpha stocks that are rated ‘overweight’ – MS
Seeking Alpha News (Tue, 19-Nov 2:40 PM ET)
J.P. Morgan Remains a Hold on Cardinal Health (CAH)
TipRanks (Tue, 19-Nov 7:07 AM ET)
Key deals this week: Exxon, Unilever, Cardinal Health, Charter Communications and more
Seeking Alpha News (Sat, 16-Nov 1:46 PM ET)
Court Square Capital Partners Announces Sale of Advanced Diabetes Supply Group
Business Wire (Tue, 12-Nov 8:00 AM ET)
Globe Newswire (Mon, 11-Nov 9:21 PM ET)
Cardinal Health announces two strategic additions to its portfolio
PRNewswire (Mon, 11-Nov 8:42 PM ET)
Cardinal Health Board of Directors Approves Quarterly Dividend
PRNewswire (Tue, 5-Nov 5:15 PM ET)
Cardinal Health Reports First Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
PRNewswire (Fri, 1-Nov 6:45 AM ET)
Cardinal Health celebrates medical product distribution center grand opening in Massachusetts
PRNewswire (Tue, 29-Oct 11:45 AM ET)
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Cardinal Health trades on the NYSE stock market under the symbol CAH.
As of November 20, 2024, CAH stock price climbed to $120.34 with 1,589,002 million shares trading.
CAH has a beta of 0.08, meaning it tends to be less sensitive to market movements. CAH has a correlation of 0.00 to the broad based SPY ETF.
CAH has a market cap of $29.12 billion. This is considered a Large Cap stock.
Last quarter Cardinal Health reported $52 billion in Revenue and $1.88 earnings per share. This beat revenue expectation by $1 billion and exceeded earnings estimates by $.26.
In the last 3 years, CAH traded as high as $126.14 and as low as $45.85.
The top ETF exchange traded funds that CAH belongs to (by Net Assets): VTI, VOO, VO, COWZ, SPY.
CAH has underperformed the market in the last year with a return of +16.2%, while SPY returned +31.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CAH shares. However, CAH has outperformed the market in the last 3 month and 2 week periods, returning +11.0% and +4.1%, while SPY returned +6.0% and -0.1%, respectively. This indicates CAH has been having a stronger performance recently.
CAH support price is $116.51 and resistance is $120.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAH shares will trade within this expected range on the day.